• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

OPKO Health

Quote

anonymous

Guest
anyone work for this company? Would love some honest feedback on culture, how rayaldee is doing, are reps making bonus, is pulling through this drug a nightmare or does it go through on a P/A? Do Nephs and Endos want to write this drug? Or do they prefer a generic calcitriol? Thanks!
 












anonymous said:
anyone work for this company? Would love some honest feedback on culture, how rayaldee is doing, are reps making bonus, is pulling through this drug a nightmare or does it go through on a P/A? Do Nephs and Endos want to write this drug? Or do they prefer a generic calcitriol? Thanks!
Click to expand...
It’s great! Most make more on bonus than on there base salary. We have managed care calling us and a bidding war has begun, demand is that great! And the best part is that we all get to pick our own flying unicorns as our company vehicle!
 








Top Bottom
Back
Quote